Mourton-Gilles C - Search Results

1

Immunogold labelling of paired helical filaments and amyloid fibrils by specific monoclonal and polyclonal antibodies.

Reig S, Buée-Scherrer V, Mourton-Gilles C, Defossez A, Delacourte A, Beauvillain JC, Mazzuca M. Reig S, et al. Acta Neuropathol. 1995;90(5):441-7. doi: 10.1007/BF00294803. Acta Neuropathol. 1995. PMID: 8560975

2

New immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease using two monoclonal antibodies against human paired helical filament tau proteins.

Condamines O, Buée-Scherrer V, Boissier L, Wattez A, Delacourte A, Pau B, Mourton-Gilles C. Condamines O, et al. Neurosci Lett. 1995 Jun 9;192(2):81-4. doi: 10.1016/0304-3940(95)11617-6. Neurosci Lett. 1995. PMID: 7675326

3

AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease.

Buée-Scherrer V, Condamines O, Mourton-Gilles C, Jakes R, Goedert M, Pau B, Delacourte A. Buée-Scherrer V, et al. Brain Res Mol Brain Res. 1996 Jul;39(1-2):79-88. doi: 10.1016/0169-328x(96)00003-4. Brain Res Mol Brain Res. 1996. PMID: 8804716

4

Biochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.

Delacourte A, Sautière PE, Wattez A, Mourton-Gilles C, Petter A, Bons N. Delacourte A, et al. C R Acad Sci III. 1995 Jan;318(1):85-9. C R Acad Sci III. 1995. PMID: 7757808

5

Phorbol ester enhances phosphorylated tau protein immunoreactivity in neuronal cultures.

Couratier P, Lesort M, Condamines O, Mourton-Gilles C, Delacourte A, Hugon J. Couratier P, et al. Neurosci Lett. 1996 Jan 26;203(3):155-8. doi: 10.1016/0304-3940(96)12302-8. Neurosci Lett. 1996. PMID: 8742016

6

Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease.

Riederer BM, Mourton-Gilles C, Frey P, Delacourte A, Probst A. Riederer BM, et al. J Neurocytol. 2001 Feb;30(2):145-58. doi: 10.1023/a:1011991207942. J Neurocytol. 2001. PMID: 11577253

7

Binding specificity of monoclonal antibody AD2: influence of the phosphorylation state of tau.

Torreilles F, Roquet F, Granier C, Pau B, Mourton-Gilles C. Torreilles F, et al. Brain Res Mol Brain Res. 2000 May 31;78(1-2):181-5. doi: 10.1016/s0169-328x(00)00073-5. Brain Res Mol Brain Res. 2000. PMID: 10891598

8

ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain.

Herrmann M, Golombowski S, Kräuchi K, Frey P, Mourton-Gilles C, Hulette C, Rosenberg C, Müller-Spahn F, Hock C. Herrmann M, et al. Eur Neurol. 1999;42(4):205-10. doi: 10.1159/000008108. Eur Neurol. 1999. PMID: 10567816

9

Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.

Molina L, Touchon J, Herpé M, Lefranc D, Duplan L, Cristol JP, Sabatier R, Vermersch P, Pau B, Mourton-Gilles C. Molina L, et al. Neuroreport. 1999 Nov 26;10(17):3491-5. doi: 10.1097/00001756-199911260-00005. Neuroreport. 1999. PMID: 10619631

10

Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer's disease and other dementias.

Abraham JD, Calvayrac-Pawlowski S, Cobo S, Salvetat N, Vicat G, Molina L, Touchon J, Michel BF, Molina F, Verdier JM, Fareh J, Mourton-Gilles C. Abraham JD, et al. Among authors: mourton gilles c. Biomarkers. 2011 Mar;16(2):161-71. doi: 10.3109/1354750X.2010.536995. Biomarkers. 2011. PMID: 21323605

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters